Hung T. Khong, MD
Associate Professor, Division of Oncology
Hung T. Khong, MD, is an associate professor in the Division of Oncology at the University of Utah and a Huntsman Cancer Institute investigator.
Khong’s research interests include cancer immunotherapy and epigenetic modulation in the treatment of cancer. His research focuses on the following:
- Adoptive cellular therapy and cancer vaccines (manipulation of the immune system to treat cancer)
- Combining treatment methods such as chemo- or radiotherapy with immunotherapy (using the immune system to enhance the effects of chemotherapy and/or radiotherapy)
- Chemotherapy with targeted therapy (drugs that intervene with specific molecules involved in tumor growth)
At the National Cancer Institute in Bethesda, Maryland, Khong was a senior clinical fellow in the surgery branch and also completed a medical oncology fellowship in the medicine branch. He completed a residency in the Internal Medicine Program at Baylor College of Medicine in Houston, Texas. Khong earned a medical degree from Temple University School of Medicine in Philadelphia, Pennsylvania.